More consolidation in Israeli generics/API sector?
Israeli press reports say US generics company IVAX is close to finalising a merger with local firm Agis, which manufactures generics and active pharmaceutical ingredients (APIs).
Archives for April 19, 2004
Illumina delivers BeadStation to customers
Illumina has announced today its latest system for performing DNA analysis using the company's proven SNP genotyping technology was being shipped worldwide to customers,writes Wai Lang Chu.
Kurve tech ahead by a nose
US company Kurve Technology has developed a nasal spray device that should make delivery of drugs in this way cheaper and more efficient.
Signs of progress in gene therapies
Growing knowledge about how to manage the risks of gene therapy could improve the chances of developing successful treatments, said experts meeting last week to weigh up the progress made on the technology to date.
Sale agreed for Dynamit Nobel
Germany's MG technologies has agreed to sell the bulk of its Dynamit Nobel chemicals division, sealing the fate of a company that has been on the block since last November, writes Phil Taylor.
Healthy growth expected for nanocatalysts
The global market for nanocatalysts will amount to $3.7 billion in 2004 and is expected to reach $5.0 billion in 2009, according to soon-to-be-released market research.
Biotica signs agreement for Inpharmatica ADME services
UK-based Inpharmatica is to provide a full range of ADME services to drug discovery company Biotica Technology under a new two-year agreement signed this week.